Gyre Therapeutics (GYRE) Capital Expenditures Growth (1y) (2011 - 2026)
Gyre Therapeutics (GYRE) Capital Expenditures Growth (1y) (2011 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Capex Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
- |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
227.76% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Gyre Therapeutics |
554.75 Mn |
540.62 Mn |
8.38 Mn |
45.90% |
| Date | Value |
|---|
| Mar 31, 2026 |
45.90% |
| Dec 31, 2025 |
321.54% |
| Sep 30, 2025 |
-3.61% |
| Jun 30, 2025 |
-82.42% |
| Mar 31, 2025 |
-47.19% |
| Dec 31, 2024 |
-102.80% |
| Sep 30, 2024 |
-64.89% |
| Jun 30, 2024 |
-41.22% |
| Mar 31, 2024 |
-86.74% |
| Sep 30, 2021 |
152.31% |
| Sep 30, 2020 |
19,400.00% |
| Jun 30, 2020 |
-67.35% |
| Mar 31, 2020 |
13.33% |
| Dec 31, 2019 |
-100.57% |
| Jun 30, 2019 |
1,533.33% |
| Mar 31, 2019 |
-92.42% |
| Dec 31, 2018 |
775.00% |
| Mar 31, 2018 |
6,500.00% |
| Dec 31, 2017 |
-83.61% |
| Mar 31, 2017 |
-96.63% |
